For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved

Certificate of analysis

Retatrutide 30mg

Lot MRT-2605-04 was tested May 4, 2026 and was assayed by an independent laboratory before release. The measured results are below.

Result summary

99.681% HPLC
99.681%
Representative HPLC profile · main peak 99.681%
Compound
Retatrutide 30mg
Lot
MRT-2605-04
Purity
99.681% by HPLC
Identity
Retatrutide
Appearance
Lyophilized powder
Tested
May 4, 2026
Verified · passed

A note on what’s shown. Manufacturer and laboratory identifiers are redacted on this lot to protect supply-chain integrity — the data is not. Purity, identity, and lot are reported exactly as measured. For research use only — not for human or veterinary use.

Looking for a different lot? Search the full lab-results library →